A s a result of biphasic changes in peripheral arterial resistance during pregnancy, the blood pressure (BP) level undergoes a gradual decrease to the nadir at midpregnancy and returns to a prepregnant level through term.
A s a result of biphasic changes in peripheral arterial resistance during pregnancy, the blood pressure (BP) level undergoes a gradual decrease to the nadir at midpregnancy and returns to a prepregnant level through term. 1, 2 Consequently, this physiological alteration leads to the question of whether the criteria for the diagnosis of gestational hypertension are suitable because the current criteria (systolic BP Emerging evidence shows that prehypertension (120-139/80-89 mm Hg), defined by the seventh report of the Joint National Committee on Prevention, 3 not only increases the risk of incident hypertension but also is associated with an increased risk of cardiovascular disease (CVD). [4] [5] [6] [7] Although prehypertension is not addressed by the eighth Joint National Committee on Prevention, 8 the diagnosis of prehypertension provides a unique understanding of when future CVD trajectories could be changed by lifestyle modifications. 4 Recent studies have demonstrated associations between prehypertension before pregnancy and hypertensive disorders during pregnancy and gestational diabetes mellitus. [9] [10] [11] To our knowledge, the association between prehypertension during pregnancy and postpartum cardiovascular risk has not been addressed.
Pregnancy is a known, long-term cardiovascular stress test for women. The presence of hypertensive disorders in pregnancy (HDP) is generally recognized as a maladaptation to pregnancyinduced hemodynamic and metabolic alterations. 12, 13 In addition,
Methods

Study Cohort
This prospective cohort study was performed in a specialized hospital for women and children in Guangzhou, the third largest city in China. The aim of the study was to investigate the antepartum and postpartum health of women and fetuses/infants. Consecutive pregnant women were considered eligible if they met the following criteria: gestational age between 11 +0 and 13 +6 weeks, singleton pregnancy, normal BP levels (<140/90 mm Hg), normal glucose and lipid profiles, nonsmokers, no history of alcohol or substance abuse, and no history of vaginal bleeding. In addition, to maximize the follow-up rate, all participants had to be registered as permanent residents of Guangzhou. Informed consent was obtained from all participants in accordance with the Declaration of Helsinki, and the study was approved by the Hospital Ethics Committee. The study design and research flowchart are shown in Figure 1 . A standardized questionnaire was completed for every participant through interviews and the review of patient medical records. The questionnaire contained demographic, medical, gynecological, obstetric and social history, as well as inquiries about body mass index before pregnancy, gestational weight gain, and the vital signs obtained during the physical examination. Obstetric measurements, ultrasound scans, and biochemical tests were also performed to ensure the medical health status of all participants and fetuses. At the end of the pregnancies, after excluding the patients with maternal and fetal abnormalities, the remaining participants with a live birth were enrolled for BP trajectory modeling (see Statistical Analysis section of this article) and postpartum follow-up. From 11 +0 to 13 +6 weeks of gestation (participant enrollment) until term, at least 7 antepartum visits were performed. The routine antepartum check-up included body weight, BP, and obstetric measurements and an ultrasound scan. All obstetric measurements were performed by well-trained midwives or obstetricians. There were no betweenmidwife variations in the mean values of the data collected, and the error rates were consistently <1% in the repeated data entry checks. The body weight and BP measurements (see below) were taken on the morning of each visit. Antepartum biochemical tests were conducted at the antenatal clinic visit closest to delivery (≥37 +0 weeks). The routine postpartum follow-up visit was performed within 6 to 12 weeks postpartum. In addition, a second follow-up visit was performed between May 1, 2011, and April 30, 2015 (0.5-3 years postpartum) to evaluate postpartum cardiometabolic risk. Body weight, BP, and waist circumference were measured.
Antepartum and Postpartum Check-Up
Venous blood samples after an overnight fast were collected at baseline (gestational ages of 11   +0   -13   +6 ), before term, and during the second postpartum follow-up to measure the levels of plasma glucose (FPG), insulin, total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, low-density lipoprotein, and free fatty acids. Insulin resistance was assessed by the homeostatic model assessment (HOMA-IR).
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Definitions
To minimize variations in BP measurement, each subject was comfortably seated with his/her back supported for at least 10 minutes of rest, and then, a standard cuff for adults fitted with a mercury sphygmomanometer was used to check BP by a trained nurse. BP was measured on the right arm by placing the stethoscope bell lightly over the brachial artery and auscultating the Korotkoff sounds. BP was usually measured once. If BP was ≥140/90 mm Hg, a second measurement was performed after at least 5 minutes of rest, and the average of the 2 BP values was recorded. Hypertension was defined by an SBP ≥140 mm Hg and DBP ≥90 mm Hg on 3 visits or by current treatment with antihypertensive medications.
During the second postpartum follow-up, the following cardiometabolic risk factors were assessed in all participants: elevated waist circumference (≥80 cm, according to specific definition for Chinese women), elevated triglycerides level (≥1.7 mmol/L), decreased HDL-C level (<1.3 mmol/L), elevated FPG level (≥5.6 mmol/L), and elevated BP level (≥135/85 mm Hg). 25 MetS was defined as the clustering of ≥3 of the risk factors listed above. 25 
Statistical Analysis
To delineate the pattern of BP changes during pregnancy, we used latent class growth modeling to identify the distinctive subgroups that shared a similar underlying BP trajectory. 26 , and 40 +0 weeks during the routine obstetric examinations at the outpatient department. Only the participants who finished the second postpartum follow-up visit were included in the models examining the associations between BP indices and MetS. The STATA procedure traj, a new plugin for estimating group-based trajectory models that is similar to a well-established SAS-based procedure (Proc Traj), 27, 28 was used for the analysis with a censored normal model that was appropriate for continuous, normally distributed data. The BP indices used for the modeling included DBP, SBP, mean arterial pressure (MAP), and mean mid-BP (calculated as [SBP+DBP]/2, a marker of coronary heart disease risk among younger populations). 29, 30 The following criteria were used to determine the number of BP trajectory groups and the trajectory shapes for each BP index 31, 32 : (1) an a priori by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from knowledge of BP development over time; (2) tendency toward a parsimonious model; (3) the difference between a simpler model and the more complex model by log Bayes Factor (higher values indicate stronger differences); and (4) each group had an average posterior probability of group membership >0.80.
Continuous variables with normal distributions are presented as the mean±SD or as medians with interquartile ranges if the data failed the normality test unless otherwise specified. Dichotomous data are presented as numbers and percentages. The differences between the groups were tested with Student t test, and categorical data were tested with the χ 2 test. Comparisons of continuous data with a skewed distribution were performed using the Mann-Whitney U test. To determine the association between BP trajectory membership of each BP index and postpartum MetS, a univariate logistic regression analysis was performed, followed by an adjustment for potential confounders that significantly differed between the MetS and the non-MetS participants. The κ statistic was used to assess the agreement between the BP trajectory-defined high-risk participants and the high-risk subjects identified by a single BP measurement at term. To construct prediction models for postpartum MetS using clinical variables at term, a receiver operator characteristic curve analysis was first used to assess the accuracy and the optimal cutoff value (the best Youden Index: sensitivity+specificity−1) of MetS-related parameters (FPG, triglycerides, HDL-C, SBP trajectories, SBP prehypertension exposure at term, SBP [as a continuous variable] at term, DBP trajectories, DBP prehypertension exposure at term, and DBP [as a continuous variable] at term) to discriminate between postpartum MetS and non-MetS participants. Subsequently, variables with a P<0.1 were included in the multivariate logistic regression model to identify the most parsimonious, clinically sound predictors of postpartum MetS. Internal validation of the prediction models was performed by bootstrapping, using 1000 random resamples from the entire data set. Model discrimination and calibration were performed using the c-statistic and the Hosmer-Lemeshow test, respectively. During the follow-up, univariate and multivariate linear regression analyses were used to establish associations between the value of the study parameters and BP levels. For all tests, a 2-tailed P<0.05 indicated statistical significance. Statistical analyses were performed using STATA version 14.1 (STATA Corp., College Station, TX).
Results
Initially, a total of 2193 normotensive pregnant women with an estimated delivery date between October 1, 2010, and September 30, 2012, were enrolled for further examinations. During the antepartum visits, 1332 women withdrew from the study, and another 354 women were excluded because of maternal and fetal abnormalities. Therefore, the postpartum follow-up was performed on 507 women with a live birth and complete data for all maternal characteristics; the BP trajectory modeling was also performed on these 507 women. A total of 311 participants finished the postpartum follow-up visit and had complete data available for analysis. After 2 participants were excluded because they did not consent to the use of the outcome data, 309 cases were analyzed, resulting in a follow-up rate of 60.9% (309/507). Notably, there was no self-reported smoking data for our cohort.
As shown in Table 1 , among the 309 participants with follow-up data, 35 participants (11.3%) had MetS. Compared with non-MetS subjects, MetS participants had more advanced maternal age, elevated free fatty acids level before delivery, higher neonatal weight, and higher prepregnancy, term, and follow-up body mass index. In addition, the MetS participants were also characterized by a progressive deterioration of insulin resistance, with a nonsignificant elevation of HOMA-IR at baseline and at term, as well as a significant increase during follow-up.
To investigate the associations between pregnancy BP indices and postpartum MetS, we first modeled the DBP, SBP, MAP, and mid-BP trajectories during pregnancy in the 507 participants. For DBP, a 3-trajectory group model with quadratic specifications for all groups was identified. The 3 discrete trajectory lines, as well as the dynamic changes in DBP and SBP levels, are plotted in Figure 2 . In this group model (Figure 2A) 2C ), respectively. Thus, this group represents individuals with BP levels similar to prehypertension. Moreover, based on a recent report on gestational age-specific reference ranges for BP in pregnancy, 33 the normal BP ranges should be between the low-J-shaped group and the moderate-U-shaped group. Consequently, the moderate-U-shaped group represents participants with BP levels between normal and prehypertension levels. Thus, our normotensive cohort-based, 3-trajectory group model is generally in agreement with a recent longitudinal study that modeled BP development in a cohort from childhood to early midlife into 4 trajectories (hypertensive, prehypertensive, high-normal, and normal). 32 The gestational BP trajectory groups for SBP, MAP, and mid-BP are shown in Figures S1 to S3 in the online-only Data Supplement.
We next examined which of the BP index-derived 3-trajectory models could best predict the occurrence of MetS postpartum. As shown in Table 2 of the 309 participants with available follow-up data, the patients in the elevated-J-shaped group had greater odds of having MetS than individuals in the low-J-shaped DBP trajectory group (odds ratio [OR], 5.16; 95% confidence interval, 1.56-17.05; P=0.007). Adjusting for the confounders that significantly differed in Table 1 (pregnancy age, body mass index [both at baseline and during follow-up], free fatty acid level, and neonatal weight) slightly increased the OR (OR, 6.55; 95% confidence interval, 1.79-23.92; P=0.004). However, patients in the moderate-U-shaped DBP trajectory did not have a statistically increased OR for having MetS. To examine the associations between a single measurement of BP, the participants were reclassified by diastolic BP (≥80 or <80 mm Hg) and SBP (≥120 or <120 mm Hg) levels at term. Compared with the patients without an elevated DBP level, the OR for postpartum MetS in patients with DBP prehypertension at term was significantly increased and remained statistically significant after adjusting for confounders (OR, 2.94; 95% confidence interval, 1.19-7.25; P=0.019). Notably, there was no association between SBP-derived, MAP-derived, and mid-BP-derived trajectory memberships, or SBP prehypertension at term, and postpartum MetS (Tables S1-S3). Because the elevated-J-shaped DBP trajectory and DBP prehypertension at term were both associated with postpartum MetS, we sought to examine the associations between these 2 DBP categories and individual cardiometabolic risk factors during follow-up. Binary logistic regression analyses (Table  S4) revealed that the elevated-J-shaped DBP trajectory was more likely to be associated with FPG and triglycerides levels, whereas an elevated DBP at term was more likely to be associated with increased waist circumference, elevated BP level, and reduced HDL-C level. In addition, when we combined the low-J-shaped and the moderated-U-shaped groups into 1 group and used the κ statistic to test the agreement between the elevated-J-shaped DBP trajectory and the elevated DBP at term, the level of agreement was considered fair, with κ=0.22 (criteria for κ value: poor if κ≤0.20; fair if κ=0.21-0.40; moderate if κ=0.41-0.60; substantial if κ=0.61-0.80; and very good if κ>0.80). 34 These results suggested that although the elevated-J-shaped DBP trajectory and DBP prehypertension at term both predicted postpartum MetS, the individuals in these 2 groups were heterogeneous.
To construct a prediction model for postpartum MetS, the receiver operator characteristic curve analyses showed that among the MetS definition-related components obtained at term (waist circumference is not applicable at this time), only FPG, triglycerides, HDL-C, and DBP trajectories had an AUC with statistical significance (Table S5) . Because HDL-C and triglycerides were inversely correlated (Pearson r=−0.309; P<0.001), we thus built 2 models (FPG+DBP trajectories+HDL-C and FPG+DBP trajectories+triglycerides). Although these 2 models had similar discrimination capacities (c-statistic, 0.755 versus 0.764, for HDL-C and triglycerides models, respectively), the model incorporating HDL-C had poor calibration (Hosmer-Lemeshow test χ 2 , 10.55; P=0.005; Table S6 and Figure S4 ). Consequently, the model incorporating FPG, DBP trajectories, and triglycerides provides the optimal prediction of postpartum MetS, with clinically acceptable discrimination (c-statistic, 0.764; 95% confidence interval, 0. Figure 3 ) capacities.
Finally, we examined the changes in the MetS definitionrelated components during follow-up. As shown in Figure 4 , compared with the MetS-related components at term, HDL-C underwent a decreasing trend with no significant difference between MetS and non-MetS participants. Despite a similar decreasing trend in triglycerides level, the reduction in MetS participants was smaller in magnitude than their non-MetS peers. The level of FPG was significantly increased during follow-up, with more obvious elevation in MetS participants. Notably, the relative changes in HOMA-IR, DBP, and SBP showed opposing trends, with increasing trends in MetS participants and decreasing trends in non-MetS participants. Multivariate linear regression analyses revealed that the levels of HOMA-IR, FPG, and triglycerides were independently associated with SBP (Table S6 ) and DBP (Table S7) during follow-up.
Discussion
Despite accumulating evidence demonstrating the association between HDP and future CVD, the association between antepartum prehypertension and postpartum cardiovascular risk has not been investigated. Using latent class growth modeling from multiple BP measurements obtained throughout the course of pregnancy, we identified 3 distinctive DBP trajectory groups during normotensive pregnancies associated with postpartum MetS. The elevated-J-shaped trajectory group (13.2% of total cohort), which is characterized by the highest DBP and SBP levels throughout pregnancy and a steep rise during the third trimester, with mean DBP and SBP levels within the range of prehypertension at term, had an ≈5-fold increase in developing postpartum MetS compared with the low-J-shaped group. Moreover, incorporating the DBP trajectory, but not the DBP prehypertension defined by a single measurement at term, with glucose and triglycerides provided a prediction model with clinically acceptable discrimination (AUC of 0.7-0.8 35 ) and good calibration. Thus, our data suggest that prehypertension identified by DBP trajectories throughout pregnancy is an independent risk factor for predicting postpartum MetS in normotensive pregnant women Interestingly, we did not observe statistical associations between the other BP-derived trajectory groups (SBP, MAP, and mid-BP) and postpartum MetS, presumably because of the more dramatic impact of pregnancy on DBP that is induced by alterations in systemic vascular resistance. 36 In fact, DBP has been shown to play a larger role in coronary heart disease risk among young to middle-aged adults. 37 Notably, although both DBP trajectories and a single DBP reading at term could identify a subset of women with higher risk of future MetS, the participants classified by these 2 approaches were heterogeneous. Moreover, a single DBP measurement did not play a statistically important role in the prediction model of postpartum MetS. In recent years, the emerging application of multiple BP measurement-derived trajectories across the lifespan has provided insights for identifying novel means of preventing future cardiovascular risk. 30, 32, 38 Therefore, considering the dynamic nature of BP during pregnancy and the impact of seasonality on pregnancy BP levels, 39 BP trajectories that are an entire pregnancy course-dependent systemic approach have potential advantages over the fragmented, single BP measurement in terms of accuracy and reproducibility. Because all pregnant women should have at least 4 antenatal care assessments according to the new World Health Organization antenatal care model, 40 full utilization of these serial BP data would thus provide additional information for future risk stratification.
There is an expanding burden of cardiometabolic risk in women, and it is a major contributor to CVD both in China and in worldwide. 41, 42 Approximately 80% of women in developed countries and 90% in developing countries will have at least 1 pregnancy in their life time. 43 Pregnancy is characterized by a cascade of physiological changes that poses a substantial burden on BP regulation, as well as on glucose and lipid metabolism. Thus, pregnancy perfectly unmasks defects in BP regulation when the body is dealing with hemodynamic alterations. In addition, the pregnancy-induced resetting of glucose and lipid homeostasis, as manifested by decreased insulin sensitivity and increased circulating triglycerides, mimic the pathological alterations observed in MetS. 44 Recent data showed that in addition to gestational diabetes mellitus, even mild forms of dysglycemia during pregnancy represent a maternal phenotype of increased subsequent cardiometabolic risk. 45 Our data revealed that the MetS participants underwent a progressive worsening of glucose metabolism from enrollment at gestational age of 11 +0 to 13 +6 weeks, to at term, and to ≈1.6 years postpartum. This finding is consistent with a recent report that β-cell function declines within the first year postpartum. 46 Moreover, our finding that HOMA-IR independently predicts postpartum BP level further supports insulin resistance as the underlying pathophysiological mechanism contributing to elevated BP level.
Our study has limitations that need to be mentioned. First, the follow-up rate in our study was ≈60%, which is generally regarded as a low rate for cohort studies. However, our cohort was drawn from a normotensive and uncomplicated population, and patients who are completely or nearly asymptomatic are less likely to be self-motivated for long-term follow-up. The low follow-up rate is a common issue for postpartum women; even among preeclamptic women with continuous medical coverage, only 57% of subjects attended a primary care visit within 1 year after delivery. 47 By applying strict enrollment criteria to exclude a potentially mobile population of young families, our study had a higher follow-up rate than previously published studies on pregnant women. 48, 49 Second, because our study is based on the Chinese population and because of the ethnic variation in the individual components of MetS, 50 the generalizability of our results to other ethnic populations warrants future analysis. Third, we did not collect data on self-reported smoking in our study, which is a well-known confounder for BP changes during pregnancy. 51 Because the smoking rate among Chinese men is ≈70%, 52 future work is warranted to examine the potential impact of passive smoking exposure using information provided by serum nicotine measurements. Fourth, as a common limitation in pregnant women, the lack of preconception information may contribute to the uncertainty of whether the elevated BP level in a subset of pregnant women is because of failed stress response to pregnancy or because of preconception disorders. However, we performed a thorough screening at baseline (11 + 0-13 +6 weeks) including glucose and lipid profiles, which could minimize the impact of this limitation. Fifth, external validation in an independent cohort is necessary, and the current DBP trajectories and related prediction model cannot be widely implemented.
Our study has the following strengths. We used a new statistical approach, latent class growth modeling, also known as group-based trajectory modeling, which was recently developed to identify clusters of individuals after a similar progression of a specific measurement over age or time. 26 This method has been utilized and reported in recent longitudinal studies involving multiple BP measurements. 30, 32, 53 To our knowledge, our report is the first to use this method to delineate BP patterns during pregnancy. Because BP measurement is a part of a routine prenatal check-up, our findings provide evidence demonstrating a novel method to cost-effectively estimate future cardiovascular risk among women. Moreover, future work is warranted to examine the potential role of a more intensive BP management strategy during pregnancy, which has been recently demonstrated to clinically benefit a nonpregnant population in the Systolic Blood Pressure Intervention Trial (SPRINT) study. 54 Early identification of metabolic risk factors and the implementation of lifestyle modifications may help delay the onset of CVD that may present 20 to 30 years after delivery and consequently improve women's health status and quality of Table 3 . CI indicates confidence interval; and HL, Hosmer-Lemeshow. 
Perspectives
The prognostic role of prehypertension (120-139/80-89 mm Hg) during pregnancy for postpartum cardiovascular risk is unclear. In this study, we prospectively evaluated the relationship between antepartum BP trajectories and the occurrence of postpartum MetS and demonstrated that the DBP trajectory within the range of prehypertension is an independent risk factor predicting postpartum MetS. This finding highlights the multiple BP measurement-dependent trajectories as a cost-effective strategy to identify subgroups of young women for whom early cardiovascular risk factor surveillance may be warranted. Table S1 .
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Figure S1
The SBP trajectory groups identified by latent class growth modeling Figure S2 The MAP trajectory groups identified by latent class growth modeling Figure S3 The mid-BP trajectory groups identified by latent class growth modeling Figure S4 Receiver operating characteristic (ROC) curve for multiple logistic regression analyses incorporating DBP trajectories, FPG and HDL-C. Figure 2) ; Codes for SBP trajectories: 1=low-J-shaped trajectory; 2=moderate-stable trajectory; 3=elevated-stable trajectory (see Supplemental Figure S1 ). respectively. The group 1is in all above three models presented with a J-shaped change during pregnancy, i.e., a slight decrease in the second trimester followed by a steeper increase in the third trimester. Additionally the best-fit model for the group 3 of all three BP indexes was a linear specification with a stable/slightly incline pattern from 11 +0 -13 +6 weeks. For the moderate BP group (group 2), a quadratic specification was found in mid-BP. Table S5 and Table S6 .
